SynthesisBlood advances2024

A Markov analysis of azacitidine and venetoclax vs induction chemotherapy for medically fit patients with AML.

Mithunan Ravindran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.